Latest news
Acoramidis Slowed the Decline in Daily Function for Amyloid Heart Disease Patients, a New Trial Analysis Finds - Medical DailyMedical Daily · Fri, 31 Jul 2026 17:00:28 GMTNew Drug Prevents Worsening Pulmonary Arterial Hypertension in Major Trial Win - MedPage TodayMedPage Today · Fri, 31 Jul 2026 07:00:00 GMTIs United Therapeutics (UTHR) Undervalued After Its Phase 3 Ralinepag Results? - simplywall.stsimplywall.st · Thu, 30 Jul 2026 16:27:53 GMTLancet Results Show Ralinepag Cut Clinical Worsening by 55 Percent in Pulmonary Arterial Hypertension - Medical DailyMedical Daily · Thu, 30 Jul 2026 07:00:00 GMTInvestigational Oral PAH Drug Cuts Clinical Worsening Risk 55% - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMT